CNS therapeutics can alter reward-related behavioral processes through targeted or non-targeted actions and thereby affect motivated behavior. Rigorous characterization and interpretation of such changes in motivated behavior can help advance our understanding of pharmacological and behavioral mechanisms through which they may be mediated. This symposium will feature presentations on recent work from several laboratories demonstrating different approaches toward studying effects of drugs on reinforcement and reward-related processes in preclinical research.